Since we identified HAVCR2 as the SPI1 target gene, we hypothesized that HAVCR2 signaling may in turn activate Spi1 expression and promote T-ALL LSC formation. The gene discussed is HAVCR2; the disease is acute lymphoblastic leukemia.